Health & Medicine

Hims' Super Bowl fallout, and the FDA reverses course

20 sec read10 views0 listens

Hims faced regulatory scrutiny following their controversial Super Bowl ad for a GLP-1 pill, while the FDA showed more leniency towards psychedelic medicines; content creators should be cautious about overhyping health products in advertisements due to potential regulatory backlash.

Read the full article at STAT News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Tech & Gadgets12 hours ago25 sec read

How Toronto is using Clariti's AI to speed up building permit approvals

Toronto has launched a one-year pilot program with Clariti's CivCheck AI software to expedite the city's building permit approval process. This initiative aims to reduce delays caused by incomplete applications, which can add significant costs for de...

Ali Nemati

Biotech & Pharma15 hours ago28 sec read

CAR T-Cell Therapy Puts Severe Rheumatoid Arthritis Into Remission in First Clinical Trial

A Phase 1 clinical trial at Charité—Universitätsmedizin Berlin has shown that CAR T-cell therapy significantly reduced disease activity in six patients with severe, treatment-refractory rheumatoid arthritis (RA), with three achieving sustained remiss...

Ali Nemati

Fitness & Wellness15 hours ago29 sec read

Google Health gets better workout logging, improved maps, and Health Connect fixes

Google Health 5.07 introduces enhanced features for workout logging, improved maps for various running conditions, and fixes for Health Connect stability issues affecting Android users. These updates address user feedback and improve navigation and f...

Ali Nemati